Definium Therapeutics (DFTX) Cash from Investing Activities (2021 - 2026)
Definium Therapeutics (DFTX) reported Cash from Investing Activities of $42.0 million for Q1 2026, up 125.85% year-over-year from $18.6 million in Q1 2025, and up 20.05% on a QoQ basis from $35.0 million in Q4 2025.
Definium Therapeutics (DFTX) has 3 years of Cash from Investing Activities data on file, last reported at $42.0 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 125.85% year-over-year to $42.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.9 million (up 132.53% YoY) and the FY2025 annual result came in at -$151.6 million, changed N/A from the prior year.
- Cash from Investing Activities rose to $42.0 million in Q1 2026 per DFTX's latest filing, from $35.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $42.0 million in Q1 2026 and bottomed at -$162.5 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - | 42.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.00 Mn |
| Mar 31, 2026 | 42.00 Mn |
| Dec 31, 2025 | 34.98 Mn |
| Dec 31, 2025 | 34.98 Mn |
| Sep 30, 2025 | 15.41 Mn |
| Sep 30, 2025 | 15.41 Mn |
| Jun 30, 2025 | -39.54 Mn |
| Jun 30, 2025 | -39.54 Mn |
| Mar 31, 2025 | -162.46 Mn |
| Mar 31, 2025 | -162.46 Mn |
| Dec 31, 2021 | 113,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Sep 30, 2021 | -27,000.00 |
| Sep 30, 2021 | -27,000.00 |
| Jun 30, 2021 | -67,000.00 |
| Jun 30, 2021 | -67,000.00 |
| Mar 31, 2021 | -316,000.00 |
| Mar 31, 2021 | -316,000.00 |